Connect Biopharma Holdings Ltd - ADR
CNTB
Get informed when a big investor buys or sells
+ FollowMarket Cap$80.59M
Close$
$0.68
36.8% downside
Current Fair Value
36.8% downsideOvervalued by 36.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $80.59 Million |
|---|---|
| Enterprise Value | $54.17 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1 |
| Beta | -0.22 |
| Outstanding Shares | 62,884,000 |
Return
| Return on Equity | -357.33% |
|---|---|
| Return on Assets | -220.79% |
| Return on Invested Capital | -363.38% |
Valuation & Multiples
| P/E Ratio | -1.45 |
|---|---|
| PEG | -4.28 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 28.33 |
| Enterprise Value to EBIT | -0.55 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 15, 2026
EPS Estimate
$-0.04
Average shareholder expectationRevenue Estimate
$9,810
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
$114,914
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 40.41% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | 18,300▼ 76.95% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 22.12%▼ 0.78% |
|---|---|
| Total Invested | $33.11M▲ 2.29% |
| Investors Holding | 57▲ 11.00% |
ESG Score
No data
About Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from its T cell-d...